David C. Klonoff

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

David C. Klonoff, John B. Buse, Loretta L. Nielsen et al. · Current Medical Research and Opinion · 2007 · 700 citations

Medicine, Endocrinology, Pharmacology +13

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

Richard M. Bergenstal, David C. Klonoff, Satish K. Garg et al. · New England Journal of Medicine · 2013 · 651 citations

Medicine, Endocrinology, Internal Medicine +17

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

Vanita R. Aroda, Julio Rosenstock, Yasuo Terauchi et al. · Diabetes Care · 2019 · 468 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

COVID-19 Pandemic: Impact of Quarantine on Medical Students’ Mental Wellbeing and Learning Behaviors

Sultan Ayoub Meo, Abdulelah Adnan Abukhalaf, Ali Abdullah Alomar et al. · Pakistan Journal of Medical Sciences · 2020 · 316 citations · Full text

Health Professions, Health Sciences, Medical Education +15

Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)

Richard M. Bergenstal, Andrew Ahmann, Timothy S. Bailey et al. · Diabetes Technology & Therapeutics · 2013 · 302 citations

Medicine, Endocrinology, Health Informatics +17